CPIX - Cumberland Pharmaceuticals Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
5.70
+0.04 (+0.71%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close5.66
Open5.61
Bid5.65 x 900
Ask12.00 x 900
Day's Range5.60 - 5.70
52 Week Range5.50 - 7.96
Volume4,738
Avg. Volume7,458
Market Cap88.738M
Beta0.45
PE Ratio (TTM)N/A
EPS (TTM)-0.30
Earnings DateNov 5, 2018 - Nov 9, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est8.75
Trade prices are not sourced from all markets
  • Exclusive: Music industry giant joins public health care company's board
    American City Business Journals2 days ago

    Exclusive: Music industry giant joins public health care company's board

    As the former chairman of RCA in Nashville and Sony Music Nashville, Joe Galante helped develop the careers of Alabama, Dave Matthews Band, Carrie Underwood, Dolly Parton and Kenny Chesney, to name a few.

  • Thomson Reuters StreetEvents24 days ago

    Edited Transcript of CPIX earnings conference call or presentation 14-Aug-18 8:30pm GMT

    Q2 2018 Cumberland Pharmaceuticals Inc Earnings Call

  • Associated Presslast month

    Cumberland: 2Q Earnings Snapshot

    On a per-share basis, the Nashville, Tennessee-based company said it had a loss of 5 cents. Earnings, adjusted for non-recurring costs and stock option expense, were 1 cent per share. The pharmaceutical ...

  • PR Newswirelast month

    Cumberland Pharmaceuticals Reports Second Quarter 2018 Financial Results

    17% Revenue Growth Over Prior Year Period NASHVILLE, Tenn. , Aug. 14, 2018 /PRNewswire/ --  Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute ...

  • ACCESSWIRElast month

    Cumberland Pharmaceuticals Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / August 14, 2018 / Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 14, 2018 at 4:30 PM ...

  • PR Newswirelast month

    Cumberland Pharmaceuticals Appoints New Senior Executive

    NASHVILLE, Tenn., Aug. 13, 2018 /PRNewswire/ -- Cumberland Pharmaceuticals (CPIX) today announced the appointment of biopharmaceutical industry veteran Adam Haeberle, Ph.D. as senior director, clinical and regulatory affairs.

  • PR Newswire2 months ago

    Cumberland Pharmaceuticals To Announce Second Quarter 2018 Financial Results

    NASHVILLE, Tenn. , Aug. 7, 2018 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release second quarter 2018 financial results after the market closes on Tuesday, ...

  • What You Must Know About Cumberland Pharmaceuticals Inc’s (NASDAQ:CPIX) Financial Strength
    Simply Wall St.4 months ago

    What You Must Know About Cumberland Pharmaceuticals Inc’s (NASDAQ:CPIX) Financial Strength

    Investors are always looking for growth in small-cap stocks like Cumberland Pharmaceuticals Inc (NASDAQ:CPIX), with a market cap of US$94.27M. However, an important fact which most ignore is: how financiallyRead More...

  • Thomson Reuters StreetEvents4 months ago

    Edited Transcript of CPIX earnings conference call or presentation 8-May-18 8:30pm GMT

    Q1 2018 Cumberland Pharmaceuticals Inc Earnings Call

  • Associated Press5 months ago

    Cumberland: 1Q Earnings Snapshot

    On a per-share basis, the Nashville, Tennessee-based company said it had a loss of 15 cents. Losses, adjusted for one-time gains and costs, came to 9 cents per share. The pharmaceutical company posted ...

  • PR Newswire5 months ago

    Cumberland Pharmaceuticals Reports First Quarter 2018 Financial Results

    - Caldolor® sNDA accepted by the FDA - Advancing four Phase II clinical programs NASHVILLE, Tenn. , May 8, 2018 /PRNewswire/ --  Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical ...

  • PR Newswire5 months ago

    Cumberland Pharmaceuticals To Announce First Quarter 2018 Financial Results

    NASHVILLE, Tenn., May 1, 2018 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (CPIX) announced today that it will release first quarter 2018 financial results after the market closes on Tuesday, May 8, 2018.  A conference call and live Internet webcast will be held on Tuesday, May 8, 2018, at 4:30 p.m. Eastern Time to discuss the results. To participate in the call, please dial 877-303-1298 (for U.S. callers) or 253-237-1032 (for international callers).  A rebroadcast of the teleconference will be available for one week and can be accessed by dialing 855-859-2056 (for U.S. callers) or 404-537-3406 (for international callers).  The Conference ID for the rebroadcast is 4296607. The live webcast and rebroadcast can be accessed via Cumberland's website at http://investor.shareholder.com/cpix/events.cfm.

  • Cumberland Pharmaceuticals Expands into Oncology Support
    PR Newswire5 months ago

    Cumberland Pharmaceuticals Expands into Oncology Support

    NASHVILLE, Tenn., April 9, 2018 /PRNewswire/ -- Cumberland Pharmaceuticals – announced today that it has expanded its medical specialties to include oncology-related medications. "Since the company's founding, Cumberland has endeavored to deliver high quality medicines to improve patient care," said CEO AJ Kazimi. As a result, quality of life becomes of paramount concern – and Cumberland's focus is on supporting cancer patients during their treatment, with the goal of improving their ongoing quality of life.

  • Why Cumberland Pharmaceuticals Inc’s (NASDAQ:CPIX) Ownership Structure Is Important
    Simply Wall St.6 months ago

    Why Cumberland Pharmaceuticals Inc’s (NASDAQ:CPIX) Ownership Structure Is Important

    Today, I will be analyzing Cumberland Pharmaceuticals Inc’s (NASDAQ:CPIX) recent ownership structure, an important but not-so-popular subject among individual investors. Ownership structure has been found to have an impact onRead More...

  • PR Newswire6 months ago

    Newly Published Data Demonstrates 85% Eradication of Ulcer Causing Bacteria

    NASHVILLE, Tenn., March 26, 2018 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (CPIX), a U.S. specialty pharmaceutical company announced today the publication of an open access article in Infection and Drug Resistance, with results demonstrating an 85% eradication rate of Helicobacter pylori (H. pylori) infection using clarithromycin-based triple therapy. Cumberland markets a branded clarithromycin-based triple therapy in the U.S. under the name Omeclamox®-Pak. H. pylori has long been known as a common pathogen associated with gastric ulcers and related dyspeptic symptoms in many infected patients.

  • Thomson Reuters StreetEvents7 months ago

    Edited Transcript of CPIX earnings conference call or presentation 6-Mar-18 9:30pm GMT

    Q4 2017 Cumberland Pharmaceuticals Inc Earnings Call

  • Associated Press7 months ago

    Cumberland reports 4Q loss

    The Nashville, Tennessee-based company said it had a loss of 5 cents per share. Earnings, adjusted for one-time gains and costs, came to 3 cents per share. The pharmaceutical company posted revenue of ...

  • PR Newswire7 months ago

    Cumberland Pharmaceuticals Reports 25% Revenue Growth For The Full Year 2017

    - National sales and distribution of Totect® initiated - New Data on Caldolor® and Vaprisol® published - Co-promotion for Kristalose® launched NASHVILLE, Tenn. , March 6, 2018 /PRNewswire/ --  Cumberland ...

  • ACCESSWIRE7 months ago

    Cumberland Pharmaceuticals Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / March 6, 2018 / Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX ) will be discussing their earnings results in their Q4 Earnings Call to be held on March 6, 2018 at 4:30 PM Eastern ...

  • PR Newswire7 months ago

    Cumberland Pharmaceuticals To Announce Fourth Quarter And Annual 2017 Financial Results

    NASHVILLE, Tenn. , Feb. 27, 2018 /PRNewswire/ --  Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release fourth quarter and annual 2017 financial results after the market closes ...

  • Why You Need To Look At This Factor Before Buying Cumberland Pharmaceuticals Inc (NASDAQ:CPIX)
    Simply Wall St.7 months ago

    Why You Need To Look At This Factor Before Buying Cumberland Pharmaceuticals Inc (NASDAQ:CPIX)

    For Cumberland Pharmaceuticals Inc’s (NASDAQ:CPIX) shareholders, and also potential investors in the stock, understanding how the stock’s risk and return characteristics can impact your portfolio is important. Every stock inRead More...

  • Is Cumberland Pharmaceuticals Inc (NASDAQ:CPIX) A Financially Sound Company?
    Simply Wall St.7 months ago

    Is Cumberland Pharmaceuticals Inc (NASDAQ:CPIX) A Financially Sound Company?

    Cumberland Pharmaceuticals Inc (NASDAQ:CPIX) is a small-cap stock with a market capitalization of US$109.29M. While investors primarily focus on the growth potential and competitive landscape of the small-cap companies, theyRead More...

  • PR Newswire8 months ago

    Newly Published Data Demonstrates Amifostine Reduces Gastro-Intestinal Toxicity For Multiple Myeloma Patients

    Amifostine may prevent gastro-intestinal toxicities in certain cancer patients. NASHVILLE, Tenn. , Jan. 30, 2018 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) , a U.S. specialty pharmaceutical ...

  • American City Business Journals9 months ago

    The fastest-growing Nashville health care company of 2017 might surprise you

    Nashville is well known for the collection of health care providers that call Music City home. Cumberland Pharmaceuticals Inc. (CPIX), a specialty pharmaceutical company founded in 1999, has seen its stock price rise more than 33 percent to $7.35, and as high as 44 percent, since the beginning of the year. Community Healthcare Trust Inc.’s stock price has risen second-fastest at almost 22 percent, as of today.

  • Is Cumberland Pharmaceuticals Inc (NASDAQ:CPIX) Excessively Paying Its CEO?
    Simply Wall St.9 months ago

    Is Cumberland Pharmaceuticals Inc (NASDAQ:CPIX) Excessively Paying Its CEO?

    A. Kazimi took the helm as Cumberland Pharmaceuticals Inc’s (NASDAQ:CPIX) CEO and grew market cap to $116.38M recently. Understanding how CEOs are incentivised to run and grow their company isRead More...